They reported a significant increase in anti-IMA950 CD8+ T-cell response in the peripheral blood from all patients post-vaccination; however, IMA950-reactive CD8+ T cells were not detected in resected tumor tissues [3]. This evidence concerns the gene CD8A and neoplasm.